Oncología

Resultados: 328
Tipo Título / Nombre Autor(es) Año
Case-control study assessing the impact of COVID19 in advanced kidney cancer patients treated with antiangiogenics or immunotherapy: the COVID-REN study García-Donas J, de Velasco G, Madurga R, Chamorro J, Rosero D..., Borrega P, et al 2023
Use of multi-gene panels in patients at high risk of hereditary digestive cancer: position statement of AEG, SEOM, AEGH and IMPaCT-GENÓMICA consortium Carballal S, Balaguer F, Bujanda L, Capellá G, Santiago SG, Jover R, et al 2023
The Role of Financial Difficulties as a Mediator between Physical Symptoms and Depression in Advanced Cancer Patients Lee EM, Jiménez-Fonseca P, Hernández R, Cruz-Castellanos P, Fernández-Montes A..., López-Ceballos H, et al 2023
What do patients and oncologists think about the evaluation and management of cancer?related anorexia?cachexia? The Quasar_ SEOM study Escobar Y, Ramchandani A, Castillo-Trujillo A, Martínez de Castro E..., Borrega P 2023
ATREZZO trial (SOLTI-1907): A phase II trial targeting estrogen receptor negative or PAM50 non-luminal disease with atezolizumab in combination with trastuzumab and vinorelbine in HER2-positive (HER2+) advanced breast cancer (ABC) - Interim analysis Ciruelos EM, Tolosa Ortega P, Salvador Bofill FJ, González Santiago S, Albacar Miro CR 2023
Time and motion randomised study of a subcutaneous (SC) pertuzumab and trastuzumab fixed-dose combination (PH FDC) for the treatment of HER2-positive early breast cancer (HER2 EBC): PHaTiMa González Santiago S, López Miranda E, Escrivá Romani S, Jiménez Rodríguez B, Antolin Novoa S, González Cortijo L, et al 2023
Infección fúngica en paciente oncológico Espacio Santos PM 2023
Síndromes paranioplásicos en carcinoma de células renales ( a propósito de un caso) Espacio Santos PM 2023
Adjuvant dabrafenib and trametinib for patients with resected BRAF-mutated melanoma: DESCRIBE-AD real-world retrospective observational study Manzano JL, Martín-Liberal J, Fernández-Morales LA, Benítez G, Medina Martínez J..., Ayala de Miguel P, et al 2023
Olaparib plus Trastuzumab in HER2[+] BRCA-Mutated Advanced Breast Cancer Patients: The OPHELIA Study Alés-Martínez JE, Balmaña J, Sánchez-Rovira P, Salvador Bofill FJ..., López Ceballos MH 2023